Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration Mar 3, 2026 10:00AM
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap May 28, 2025 06:05AM
Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025 May 22, 2025 05:05PM
Exact Sciences Earns 2025 Great Place To Work® Certification™ May 12, 2025 10:00AM
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025 Apr 29, 2025 06:59AM
View Older Stories

Apr 22, 2025 06:00AM Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
Apr 14, 2025 06:00AM JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
Mar 31, 2025 06:00AM Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
Mar 12, 2025 09:00AM Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
Jan 21, 2025 05:05PM Exact Sciences (EXAS): New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
Jan 21, 2025 05:05PM  Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
Jan 21, 2025 05:05PM New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
Jan 12, 2025 07:00PM Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
Nov 25, 2024 05:35PM Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
Nov 13, 2024 01:01PM Exact Sciences (EXAS) Unveils Data Showing Promise of Multi-Cancer Early Detection
Nov 13, 2024 01:00PM Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
Oct 27, 2024 12:00PM Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
Oct 4, 2024 06:03AM Exact Sciences (EXAS) Announces FDA Approval of Cologuard Plus Test
Oct 4, 2024 06:00AM FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
Sep 16, 2024 07:16AM Exact Sciences (EXAS) Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
Sep 16, 2024 02:35AM Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
Aug 28, 2024 06:00AM Exact Sciences to Participate in September Investor Conferences
Aug 20, 2024 07:01AM Exact Sciences (EXAS) Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
Aug 20, 2024 07:00AM Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
Aug 15, 2024 07:00AM New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
Jul 31, 2024 04:05PM Exact Sciences (EXAS) and TwinStrand Biosciences Enter Exclusive License Agreement for Duplex Sequencing Technology
Jul 31, 2024 04:05PM TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology
Jul 31, 2024 04:05PM Exact Sciences Announces Second-Quarter 2024 Results
Jul 8, 2024 06:00AM Exact Sciences schedules second quarter 2024 earnings call
May 28, 2024 06:00AM Exact Sciences to Participate in June Investor Conferences
May 24, 2024 06:05AM Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
May 22, 2024 07:30AM Exact Sciences Earns 2024 Great Place To Work® Certification™
May 21, 2024 06:06AM Exact Sciences (EXAS) Reports Court Rules the Company to Proceed with Lawsuit against Geneoscopy
May 21, 2024 06:05AM Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
May 8, 2024 04:05PM Exact Sciences Announces First-Quarter 2024 Results
May 7, 2024 08:00AM Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
May 1, 2024 06:00AM Exact Sciences to Participate in May Investor Conference
Apr 15, 2024 06:01AM Exact Sciences (EXAS) Appoints Aaron Bloomer as CFO
Apr 15, 2024 06:00AM Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
Apr 11, 2024 06:02AM Exact Sciences (EXAS) Announces Debt Exchange Transaction, Private Convertible Notes Placement
Apr 11, 2024 06:00AM Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
Apr 8, 2024 12:05PM Exact Sciences (EXAS) to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR
Apr 8, 2024 12:05PM Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
Apr 8, 2024 06:00AM Exact Sciences Schedules First Quarter 2024 Earnings Call
Apr 4, 2024 06:05AM Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
Mar 28, 2024 06:02AM Exact Sciences (EXAS) Advances Development of Non-Endoscopic Oncoguard Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Mar 28, 2024 06:00AM Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Mar 27, 2024 08:05AM Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
Mar 13, 2024 05:03PM The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Mar 7, 2024 07:59AM Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
Feb 26, 2024 06:00AM Exact Sciences to Participate in March Investor Conference
Feb 21, 2024 04:05PM Exact Sciences Announces Fourth Quarter 2023 Results
Feb 1, 2024 06:00AM Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
Jan 8, 2024 05:24AM Exact Sciences (EXAS) Reports Prelim Q4 Results
Jan 7, 2024 04:30PM Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
View Older Stories